IKBKB Produkte
(Inhibitor of kappa Light Polypeptide Gene Enhancer in B-Cells, Kinase beta (IKBKB))
Kategorien
The protein encoded by this gene phosphorylates the inhibitor in the inhibitor/NF-kappa-B complex, causing dissociation of the inhibitor and activation of NF-kappa-B. The encoded protein itself is found in a complex of proteins. Several transcript variants, some protein-coding and some not, have been found for this gene. [provided by RefSeq, Sep 2011].
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Ausgewählte IKBKB Kategorien
IKBKB Antikörper
High quality antibodies with extensive validation data.
IKBKB ELISA Kits
Reliable ELISA kits for a wide range of species.
IKBKB Proteine
Proteins for various applications incl. WB, ELISA, IF etc.
Empfohlene IKBKB Antikörper
Produkt
Reaktivität
Applikation
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Applikation
WB, IHC
Validierungen
- (2)
- (10)
Kat. Nr.
ABIN3022876
Menge
100 μL
Datenblatt
Datenblatt
Reaktivität
Human
Applikation
WB, IF, IHC (p), ICC
Validierungen
- (5)
Kat. Nr.
ABIN2856162
Menge
100 μL
Datenblatt
Datenblatt
Reaktivität
Human, Monkey, Mouse, Rat
Applikation
ELISA, WB, IHC, IF, ICC
Validierungen
- (1)
- (4)
Kat. Nr.
ABIN6256667
Menge
100 μL
Datenblatt
Datenblatt
Empfohlene IKBKB ELISA Kits
Produkt
Reaktivität
Analytical Method
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Rat
Analytical Method
Quantitative Sandwich ELISA
Validierungen
- (1)
Kat. Nr.
ABIN6967598
Menge
96 tests
Datenblatt
Datenblatt
Reaktivität
Human
Analytical Method
Quantitative Sandwich ELISA
Validierungen
- (1)
Kat. Nr.
ABIN6967597
Menge
96 tests
Datenblatt
Datenblatt
Reaktivität
Human
Analytical Method
Quantitative Sandwich ELISA
Validierungen
- (1)
Kat. Nr.
ABIN6956743
Menge
96 tests
Datenblatt
Datenblatt
Empfohlene IKBKB Proteine
Produkt
Reaktivität
Source
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Source
Wheat germ
Validierungen
- (1)
- (1)
Kat. Nr.
ABIN1307638
Menge
10 μg
Datenblatt
Datenblatt
Reaktivität
Human
Source
Escherichia coli (E. coli)
Validierungen
- (1)
Kat. Nr.
ABIN7123430
Menge
50 μg
Datenblatt
Datenblatt
Reaktivität
Human
Source
Wheat germ
Validierungen
- (1)
Kat. Nr.
ABIN1307640
Menge
10 μg
Datenblatt
Datenblatt
Neueste Publikationen zu unseren IKBKB Produkten
: "Inhibition of DNM1L and mitochondrial fission attenuates inflammatory response in fibroblast-like synoviocytes of rheumatoid arthritis." in: Journal of cellular and molecular medicine, Vol. 24, Issue 2, pp. 1516-1528, (2021) (PubMed).: "Paeonol attenuates inflammation by targeting HMGB1 through upregulating miR-339-5p." in: Scientific reports, Vol. 9, Issue 1, pp. 19370, (2020) (PubMed).
: "NFκB signaling in alveolar rhabdomyosarcoma." in: Disease models & mechanisms, Vol. 10, Issue 9, pp. 1109-1115, (2018) (PubMed).
: "Nuclear Localization Leucine-Rich-Repeat Protein 1 Deficiency Protects Against Cardiac Hypertrophy by Pressure Overload." in: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, Vol. 48, Issue 1, pp. 75-86, (2018) (PubMed).
: "Uncovering inherent cellular plasticity of multiciliated ependyma leading to ventricular wall transformation and hydrocephalus." in: Nature communications, Vol. 9, Issue 1, pp. 1655, (2018) (PubMed).
: "Mechanism of dysfunction of human variants of the IRAK4 kinase and a role for its kinase activity in interleukin-1 receptor signaling." in: The Journal of biological chemistry, Vol. 293, Issue 39, pp. 15208-15220, (2018) (PubMed).
: "Broadleaf Mahonia attenuates granulomatous lobular mastitis‑associated inflammation by inhibiting CCL‑5 expression in macrophages." in: International journal of molecular medicine, Vol. 41, Issue 1, pp. 340-352, (2018) (PubMed).
: "Src Promotes Metastasis of Human Non-Small Cell Lung Cancer Cells through Fn14-Mediated NF-κB Signaling." in: Medical science monitor : international medical journal of experimental and clinical research, Vol. 24, pp. 1282-1294, (2018) (PubMed).
: "TNFα-YAP/p65-HK2 axis mediates breast cancer cell migration." in: Oncogenesis, Vol. 6, Issue 9, pp. e383, (2017) (PubMed).
: "Inflammation Improves Glucose Homeostasis through IKKβ-XBP1s Interaction." in: Cell, Vol. 167, Issue 4, pp. 1052-1066.e18, (2016) (PubMed).
Synonyme und alternative Namen zu IKBKB
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta L homeolog (ikbkb.L), inhibitor of nuclear factor kappa B kinase subunit beta (IKBKB), inhibitor of nuclear factor kappa B kinase subunit beta (ikbkb), I-kappaB kinase beta (IKKbeta), inhibitor of nuclear factor kappa B kinase subunit beta (Ikbkb), inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (IKBKB), inhibitor of kappaB kinase beta (Ikbkb), AI132552, AIM-1, anon-89Bd, CG4201, DIK, dIKK, dIKK-beta, dIKKbeta, DLAK, dLak, Dmel\\CG4201, DmIKK, DmIKKb, Dmikkb, DmIKKBeta, DmIKKbeta, DmIkkbeta, Dmikkbeta, dmIKKbeta, IK, Ik, IKBKB, IKK, ikk, IKK-2, ikk-beta, IKK-beta, ikk2, IKK2, ikkb, IKKB, IKKb, Ikkb, ikkbeta, IKKbeta, Ikkbeta, IKK[b], ird, IRD-5, Ird-5, IRD5, Ird5, ird5/DmIkk[beta], Lak, LRK, NFKBIKBBezeichner auf Proteinebene für IKBKB
- inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
- inhibitor of nuclear factor kappa-B kinase subunit beta
- inhibitor of nuclear factor kappa-B kinase subunit beta-like
- CG4201-PB
- IKK-like protein
- LPS-responsive kinase
- LPS-responsive-kinase
- cactus kinase
- deficient 5
- immune response
- ird5-PB
- lipopolysaccharide activated kinase
- mmune response deficient 5
- I-kappa-B kinase 2
- I-kappa-B-kinase beta
- IKK-B
- nuclear factor NF-kappa-B inhibitor kinase beta
- IKK-beta
- NFKBIKB
- inhibitor of kappaB kinase beta
- inhibitor of nuclear factor kappa B kinase beta subunit
- inhibitor of kappa light chain gene enhancer in B cells, kinase beta
- IKK2
Sie sind hier:
